Clinical Trials Logo
  1. Home
  2. Adjuvant Chemotherapy
  3. NCT06389552

Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients

Adjuvant Chemotherapy Clinical Trial

Official title:
A Long-term Follow-up Study of FOLFIRINOX Regimen as Adjuvant Therapy in Pancreatic Cancer Patients After Curative Surgery: Multi-center, Prospective

Clinical Trial Summary

This study is designed to evaluate the safety and efficacy of adjuvant FOLFIRINOX regimen in pancreatic cancer patients after curative surgery.

Clinical Trial Description

This study is multi-center, prospective, long-term follow-up observational study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06389552
Study type Observational
Source HK inno.N Corporation
Contact Soyeon Ahn
Phone 82-2-6477-0252
Email soyeon.ahn@inno-n.com
Status Recruiting
Phase
Start date September 25, 2023
Completion date December 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05613465 - Adjuvant Chemotherapy Plus Codonopsis Pilosula Nnannf /Placebo N/A
Terminated NCT03702868 - Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer
Recruiting NCT03748680 - IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer Phase 2
Completed NCT03079427 - Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma Phase 2
Withdrawn NCT03228043 - Apatinib for Resectable Colorectal Cancer N/A
Recruiting NCT03468010 - A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement) Phase 3
Recruiting NCT03199989 - Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) Phase 3
Completed NCT03213444 - Impact of Adjuvant Chemotherapy in Patients With Colon Cancer N/A
Terminated NCT04070313 - A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan Phase 2
Recruiting NCT05735145 - Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer Phase 3
Terminated NCT02492477 - TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients Phase 1
Completed NCT02312284 - Observational Study on the Patients With Rectal Cancer N/A
Active, not recruiting NCT04564157 - New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy Phase 3
Recruiting NCT03448549 - SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients Phase 3
Not yet recruiting NCT01261962 - Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer N/A
Recruiting NCT01125020 - Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation N/A
Terminated NCT03858166 - Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer Phase 4
Not yet recruiting NCT04303429 - Adjuvant Chemotherapy in High Risk Stage II Colon Cancer Phase 3
Recruiting NCT03748485 - Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis N/A